Nebulized Hypertonic Saline Use in Bronchiectasis

Recommended Usage Protocol

The British Thoracic Society recommends nebulized hypertonic (3%) saline should be used before airway clearance techniques, typically once or twice daily in patients with bronchiectasis, particularly those with viscous secretions or evidence of sputum plugging 1, 2
Hypertonic saline (3%) should be administered as part of a stepwise approach to airway clearance, used when standard airway clearance techniques alone are not effective 1
The medication should be administered in the following sequence:

Hypertonic saline works by increasing mucociliary clearance in diseased lungs and may help rehydrate airway surface liquid, though evidence for the specific mechanism remains indirect 3

For patients with more severe symptoms or during exacerbations, the frequency of airway clearance techniques should be increased, which may include more frequent use of hypertonic saline 4
Individual response should be evaluated, as recommended by the European Respiratory Society guidelines which suggest an "n of one" trial to determine benefit for the specific patient 5, 6

Higher concentrations (6-7%) of hypertonic saline may provide additional benefits in selected patients with high symptom burden, frequent exacerbations, or difficulty with expectoration 7
Short-acting β2-agonists should be used prior to inhaling hypertonic saline to prevent bronchospasm, especially when using higher concentrations 7
The first dose of hypertonic saline should be administered under medical supervision, particularly when using higher concentrations 7

In children and adolescents with bronchiectasis, the European Respiratory Society suggests that hypertonic saline not be used routinely but may be considered in selected patients with high daily symptoms, frequent exacerbations, difficulty with expectoration, or poor quality of life 7
Patients should be old enough to tolerate the intervention, and the treatment should be individualized based on developmental and age-appropriate considerations 7